Pegylated interferon alpha – 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial - Concepedia

Concepedia

Publication | Closed Access

Pegylated interferon alpha – 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial

37

Citations

30

References

2017

Year

Krisstina Gowin, Tania Jain, Heidi Kosiorek, Raoul Tibes, John Camoriano, Jeanne Palmer, Ruben A. Mesa

Leukemia Research

Hematological MalignancyMedicineHematologyImmunologyPathologyInterferon AlphaOncologyMyeloproliferative Neoplasm PatientsMyeloid Neoplasia

References

	Year	Citations

Page 1